Panel 1: Defining & Assessing Drug Value (Unpacking Drug Value) | Kaiser Permanente
Channel: Kaiser Permanente
Date: 2019-09-24

Maisha Draves, MD, MPH
Medical Director of Pharmacy
The Permanente Medical Group
Kaiser Permanente

Sarah K. Emond, MPP
Executive Vice President and Chief Operating Officer
Institute for Clinical and Economic Review

Mark E. Miller, PhD
Executive Vice President, Health Care
Arnold Ventures

Rena Conti, PhD
Associate Professor
Department of Markets, Public Policy and Law
Questrom School of Business
Boston University

Chris Leibman, PharmD, MS
Senior Vice President, Value & Access
Biogen

Center for Total Health, Washington, D.C.
September 13, 2019